EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Harnessing Attenuation-Related Mutations of Viral Genomes: Development of a Serological Assay to Differentiate between Capripoxvirus-Infected and -Vaccinated Animals

Francisco J Berguido, Tesfaye Rufael Chibssa, Angelika Loitsch, Yang Liu, Kiril Krstevski iD, Igor Djadjovski iD, Eeva Tuppurainen, Tamaš Petrović iD, Dejan Vidanović iD, Philippe Caufour iD, Tirumala Bharani K Settypalli iD, Clemens Grünwald-Gruber und 4 weitere

Viruses · 2023

DOI: 10.3390/v15122318 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Francisco J Berguido und 15 weiteren Autor:innen. Beteiligte Einrichtung: Animal Production and Health Laboratory, Animal Production and Health Section, Joint FAO/IAEA Division, Department of Nuclear Sciences and Applicatio…. Hauptthemen laut MEDLINE: Capripoxvirus, Lumpy skin disease virus, Poxviridae Infections, Viral Vaccines. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Peaceful Uses Initiatives (PUI) by Japan and the United States of America.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sheeppox, goatpox, and lumpy skin disease caused by the sheeppox virus (SPPV), goatpox virus (GTPV), and lumpy skin disease virus (LSDV), respectively, are diseases that affect millions of ruminants and many low-income households in endemic countries, leading to great economic losses for the ruminant industry. The three viruses are members of the Capripoxvirus genus of the Poxviridae family. Live attenuated vaccines remain the only efficient means for controlling capripox diseases. However, serological tools have not been available to differentiate infected from vaccinated animals (DIVA), though crucial for proper disease surveillance, control, and eradication efforts. We analysed the sequences of variola virus B22R homologue gene for SPPV, GTPV, and LSDV and observed significant differences between field and vaccine strains in all three capripoxvirus species, resulting in the truncation and absence of the B22R protein in major vaccines within each of the viral species. We selected and expressed a protein fragment present in wildtype viruses but absent in selected vaccine strains of all three species, taking advantage of these alterations in the B22R gene. An indirect ELISA (iELISA) developed using this protein fragment was evaluated on well-characterized sera from vaccinated, naturally and experimentally infected, and negative cattle and sheep. The developed wildtype-specific capripox DIVA iELISA showed >99% sensitivity and specificity for serum collected from animals infected with the wildtype virus. To the best of our knowledge, this is the first wildtype-specific, DIVA-capable iELISA for poxvirus diseases exploiting changes in nucleotide sequence alterations in vaccine strains.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CapripoxvirusLumpy skin disease virusPoxviridae InfectionsViral VaccinesSheep DiseasesSheepCattleAnimalsMutationGenome, ViralGoats

Stichwörter der Autor:innen

B22RDIVAGTPVKSGP 0240 (KS-1) vaccineLSDVSPPVcapripoxvirusiELISAneethlingserology

Substanzen

Viral Vaccines

Autor:innen und Institutionen

  • Animal Production and Health Laboratory, Animal Production and Health Section, Joint FAO/IAEA Division, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, WagramerStrasse 5, P.O. Box 10…
  • Institute of Biotechnology, University of Natural Resources and Life Sciences (BOKU), Muthgasse 18, 1190 Vienna, Austria.
  • Animal Health Institute, Sebeta P.O. Box 4, Ethiopia.
  • Austrian Agency for Health and Food Safety (AGES), Spargelfeldstrasse 191, 1220 Vienna, Austria.
  • China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.
  • Faculty of Veterinary Medicine, Ss. Cyril and Methodius University in Skopje, 1000 Skopje, North Macedonia.

ORCID-Profile: Kiril Krstevski, Igor Djadjovski, Tamaš Petrović, Dejan Vidanović, Philippe Caufour, Tirumala Bharani K Settypalli, Reingard Grabherr, Charles Euloge Lamien

Förderung

  • Peaceful Uses Initiatives (PUI) by Japan and the United States of America

Zitieren

APA

Berguido, F. J., Chibssa, T. R., Loitsch, A., Liu, Y., Krstevski, K., Djadjovski, I., Tuppurainen, E., Petrović, T., Vidanović, D., Caufour, P., Settypalli, T. B. K., Grünwald-Gruber, C., Grabherr, R., Diallo, A., Cattoli, G., & Lamien, C. E. (2023). Harnessing Attenuation-Related Mutations of Viral Genomes: Development of a Serological Assay to Differentiate between Capripoxvirus-Infected and -Vaccinated Animals. Viruses. https://doi.org/10.3390/v15122318

Vancouver

Berguido FJ, Chibssa TR, Loitsch A, Liu Y, Krstevski K, Djadjovski I, et al. Harnessing Attenuation-Related Mutations of Viral Genomes: Development of a Serological Assay to Differentiate between Capripoxvirus-Infected and -Vaccinated Animals. Viruses. 2023. doi:10.3390/v15122318

BibTeX
@article{Berguido2023,
  author = {Berguido, Francisco J and Chibssa, Tesfaye Rufael and Loitsch, Angelika and Liu, Yang and Krstevski, Kiril and Djadjovski, Igor and Tuppurainen, Eeva and Petrović, Tamaš and Vidanović, Dejan and Caufour, Philippe and Settypalli, Tirumala Bharani K and Grünwald-Gruber, Clemens and Grabherr, Reingard and Diallo, Adama and Cattoli, Giovanni and Lamien, Charles Euloge},
  title = {Harnessing Attenuation-Related Mutations of Viral Genomes: Development of a Serological Assay to Differentiate between Capripoxvirus-Infected and -Vaccinated Animals},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15122318}
}
Kostenlos starten →